Medical Marijuana ProCon .org |
HOME | CLOSE |
| 1. | Name: | Margaret Haney, PhD | |||||||||
| 2. | Title: | Associate Professor of Clinical Neuroscience at Columbia University | |||||||||
| 3. | Medical Marijuana Position: |
Pro to the question "Should marijuana be a medical option?" | |||||||||
| 4. | Reasoning: |
"As compared with placebo, marijuana and dronabinol dose dependently increased daily caloric intake and body weight in HIV-positive marijuana smokers. All cannabinoid conditions produced significant intoxication, except for low-dose dronabinol (5 mg); the intoxication was rated positively (eg, 'good drug effect') with little evidence of discomfort and no impairment of cognitive performance. Effects of marijuana and dronabinol were comparable, except that only marijuana (3.9% THC) improved ratings of sleep. Conclusions: These data suggest that for HIV-positive marijuana smokers, both dronabinol (at doses 8 times current recommendations) and marijuana were well tolerated and produced substantial and comparable increases in food intake." |
|||||||||
| 5. |
Credibility Ranking: |
ExpertsPhD's and JD's (lawyers) with significant post-doctoral involvement in medical marijuana issues; judges who have presided over medical marijuana cases. |
|||||||||
| 6. | Involvement: |
| |||||||||
| 7. | Education: |
| |||||||||
| 8. | Relevant Affiliations/Honors: |
None found
|
|||||||||
| 9. | Contact Info: |
|
|||||||||
| 10. | Other: |
Select Publications:
|
|||||||||
